Phlow Corp. applauds the Executive Order issued by the President of the United States to ensure American pharmaceutical supply chain resiliency by ...

A nonprofit is nearing completion on a facility that will make generic versions of three types of insulin. It will sell them for no more than $30 a vial.

Not for distribution to U.S. news wire services or dissemination in the United States.